Startseite>>Labeling & Detection>> BODIPY FL Dyes>>BODIPY 630/650X succinimide ester

BODIPY 630/650X succinimide ester (Synonyms: BODIPY 630/650X SE)

Katalog-Nr.GC42962

BODIPY 630/650X Succinimidester ist ein fluoreszierendes Konjugat des Adenosinrezeptorliganden N-Ethylcarboxamido-Adenosin (NECA).

Products are for research use only. Not for human use. We do not sell to patients.

BODIPY 630/650X succinimide ester Chemische Struktur

Cas No.: 380367-48-6

Größe Preis Lagerbestand Menge
1mg
153,00 $
Auf Lager
5mg
457,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BODIPY 630/650X succinimide ester (SE) is an amine-reactive fluorescent probe that contains an integrated aminohexanoyl linker (X). [1][2]  It displays excitation/emission maxima of 630/650 nm, respectively. BODIPY 630/650X SE has been used, linked to adenosine A1 receptor ligands, as a fluorescent probe to quantify ligand-receptor binding using fluorescence correlation spectroscopy. [1][2]

Reference:
[1]. Briddon, S.J., Middleton, R.J., Cordeaux, Y., et al. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. Proc. Natl. Acad. Sci. U.S.A. 101(13), 4673-4678 (2004).
[2]. Dale, C.L., Hill, S.J., and Kellam, B. New potent, short-linker BODIPY-630/650™ labelled fluorescent adenosine receptor agonists. Med. Chem. Commun. 3(3), 333-338 (2012).

Bewertungen

Review for BODIPY 630/650X succinimide ester

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BODIPY 630/650X succinimide ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.